Salt Lake City, UT, United States of America

Marcos Daccarett

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator in Atrial Fibrillation Treatment: The Contributions of Marcos Daccarett

Introduction: Marcos Daccarett, a prominent inventor based in Salt Lake City, Utah, has made significant strides in the field of medical technology. With a focus on the treatment of atrial fibrillation, his innovative work has the potential to advance patient care and improve treatment outcomes. Daccarett holds one patent related to his groundbreaking invention, showcasing his commitment to revolutionizing cardiac health.

Latest Patents: Daccarett's patent titled "Systems and methods for administering treatment of atrial fibrillation" is a notable advancement in medical technology. This invention details methods and systems designed specifically for the treatment of atrial fibrillation. Key aspects of the patent include assessing a patient's risk of thromboembolic stroke by acquiring image data and determining indicators of fibrosis within the left atrium (LA). Based on this analysis, a tailored treatment modality is administered, underscoring the innovative approach Daccarett has taken towards enhancing patient outcomes.

Career Highlights: Marcos Daccarett's career is marked by a dedicated focus on medical research and innovation. He is affiliated with the University of Utah Research Foundation, where he collaborates on cutting-edge projects aimed at improving cardiac health. His work exemplifies the intersection of technology and healthcare, bridging the gap between research and practical application.

Collaborations: In his pursuit of innovation, Daccarett has collaborated with esteemed colleagues such as Nassir F. Marrouche and Rob MacLeod. These collaborations reflect his commitment to teamwork and interdisciplinary research, fostering a conducive environment for groundbreaking advancements in atrial fibrillation treatment.

Conclusion: Marcos Daccarett's contributions to the field of atrial fibrillation treatment through his patented invention reflect the vital role of innovation in healthcare. His dedication to improving the lives of patients with cardiac conditions is commendable. As the medical field continues to evolve, inventors like Daccarett are at the forefront of pioneering solutions that enhance patient care and treatment efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…